Clinical Trial Update: GDNF in ideopathicParkinsons Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating GDNF for idiopathic Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinsonian Disorder
• Parkinson Disease

Drugs mentioned

• GDNF (glial cell line-derived neurotrophic factor)

Snippet

Sponsor: North Bristol NHS Trust | Conditions: Idiopathic Parkinson Disease | Phase 2 | Status: COMPLETED